STOCK TITAN
  1. Home
  2. Sec-filings
  3. RANI
  4. [EFFECT] Rani Therapeutics Holdings, Inc. SEC Filing

[EFFECT] Rani Therapeutics Holdings, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 11, 2025 4:00 P.M.
Form: S-3
CIK: 0001856725
Company Name: Rani Therapeutics Holdings, Inc.
File Number: 333-288509

Source: View Original Filing on SEC EDGAR

Stock RANI logo
Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

RANI Rankings

#4828 Ranked by Market Cap
N/A Ranked by Dividends

RANI Latest News

Jan 28, 2026
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
Jan 8, 2026
Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen
Nov 24, 2025
Rani Therapeutics to Participate in the Evercore Healthcare Conference
Nov 6, 2025
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
Oct 30, 2025
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025

RANI Latest SEC Filings

Feb 13, 2026
[SCHEDULE 13G] Rani Therapeutics Holdings, Inc. Passive Investment Disclosure (>5%)
Feb 12, 2026
[SCHEDULE 13G] Rani Therapeutics Holdings, Inc. Passive Investment Disclosure (>5%)
Jan 30, 2026
[SCHEDULE 13G] Rani Therapeutics Holdings, Inc. Passive Investment Disclosure (>5%)
Dec 5, 2025
[DEF 14C] Rani Therapeutics Holdings, Inc. Definitive Information Statement
Nov 25, 2025
[PRE 14C] Rani Therapeutics Holdings, Inc. Preliminary Information Statement

RANI Stock Data

134.62M
91.96M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN JOSE